//www.kolayalmanca.com/ 2018-09-04T19：05：23+00：00 1.00 //www.kolayalmanca.com/about/ 2018-09-04T19：05：23+00：00 0.80 //www.kolayalmanca.com/news/ 2018-09-04T19：05：23+00：00 0.80 //www.kolayalmanca.com/contact/ 2018-09-04T19：05：23+00：00 0.80 //www.kolayalmanca.com/our-pipeline/ 2018-09-04T19：05：23+00：00 0.64 //www.kolayalmanca.com/content/gritstone-oncology-to-present-first-first-data-bridging-tumor-antigen-sidentife------------ antigen-potent-potent-potent-potent-inmumunotheraphy-rimates-in-at-at-at-at-at-at-at-aacr-acr-nual-nual-nual--会议/ 2018-09-04T19：05：23+00：00 0.64 //www.kolayalmanca.com/content/gritstone-oncology-appoints-jayant-jayant-phale-ph-d-d-d-as-cectecte-dectection-vice-vice-president-president-presindent-oftechnical-operations/ 2018-09-04T19：05：23+00：00 0.64 //www.kolayalmanca.com/content/gritstone-oncology-oncology-appoints-jean-marc-bellemin-as-chief-financial-financial-financial officer/ 2018-09-04T19：05：23+00：00 0.64 //www.kolayalmanca.com/content/gritstone-oncology-opens-oncens-new-state-op-the-art-personal-cancer-cancer-mmunotherapy-manufacturing-facility/ 2018-09-04T19：05：23+00：00 0.64 //www.kolayalmanca.com/content/gritstone-oncology-and-arbutus-biopharma-announce-lnp-technology-licensing-agreement-to-develop-novel-rna-based-personalized-neoantigen-immunotherapies-for-cancer-患者/ 2018-09-04T19：05：23+00：00 0.64 //www.kolayalmanca.com/content/gritstone-oncology-secures-secures-92-70万英寸Series-b-financing/ 2018-09-04T19：05：23+00：00 0.64 //www.kolayalmanca.com/content/gritstone-oncology-expands-scientific-ascientific-advisory-board-board-with-appoint-r-mmmuno-oncology-oncology-ncology-encology-experts-experts-james-l-gulley and-gulley and-alsessandro-setter/ 2018-09-04T19：05：23+00：00 0.64 //www.kolayalmanca.com/content/gritstone-oncology-ancology-appoints-raphael-f-rousseau-m-d-ph-d-d-d-ph-d-bas-chief-medical-medical/ 2018-09-04T19：05：23+00：00 0.64 //www.kolayalmanca.com/content/first-public-data-presented-from-gritstone-oncologys-tumor-antigen-sindiendification-platform-platform-for-per-per-per-per-per-personalized-cancer-cancers-immunotherapy/munotherapy/ 2018-09-04T19：05：23+00：00 0.64 //www.kolayalmanca.com/content/gritstone-oncology-to-present-present-at-cowen-and-companys-37th-andual-health-health-care-conference/ 2018-09-04T19：05：23+00：00 0.64 //www.kolayalmanca.com/content/immune-design-and-ritstone-oncology-annouse-clinical-collaboration-for-neoantigen-cancer-cancer-mmunother/ 2018-09-04T19：05：23+00：00 0.64